Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance

AIDS

Volumn 11, Issue 12, 1997, Pages 1473-1478

  Perlman, David C ^a   El Sadr, Wafaa M ^b   Heifets, Leonid B ^c   Nelson, Eileen T ^d   Matts, John P ^d   Chirgwin, Keith ^e   Salomon, Nadim ^a   Telzak, Edward E ^f   Klein, Oscar ^g   Kreiswirth, Barry N ^h   Musser, James M ⁱ   Hafner, Richard ^j  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b HARLEM HOSPITAL CENTER   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f BRONX LEBANON HOSPITAL CENTER   (United States)

^g St Vincent's Hospital   (United States)

^h PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

ⁱ HOUSTON METHODIST HOSPITAL   (United States)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

more..

Author keywords

Drug resistance; Fluoroquinolones; Levofloxacin; Mycobacterium tuberculosis; Tuberculosis

Indexed keywords

LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL TRIAL; CODON; DISEASE ASSOCIATION; DRUG SENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MISSENSE MUTATION; MOLECULAR GENETICS; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STATISTICS; TUBERCULOSIS; AIDS RELATED COMPLEX; ANTIBIOTIC RESISTANCE; CASE REPORT; DRUG COMBINATION; DRUG EFFECT; GENETICS; IN VITRO STUDY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; SPUTUM;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ETHAMBUTOL; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; PYRAZINAMIDE; RIFAMPIN; SPUTUM; TUBERCULOSIS;

EID: 0031254565     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199712000-00011     Document Type: Article

References (27)

1. Raviglione M, Snider D, Kochi A: Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995, 273:220-226.
2. Bloch AB, Simone PM, McCray E, Castro KG: Preventing multidrug resistant tuberculosis. JAMA 1996, 275:487-489.
3. Perlman DC, Hanvanich M: Prophylaxis and treatment of HIV-related tuberculosis. AIDS 1997, 11 (suppl A):S175-S179.
4. Heifets LB, Lindholm-Levy PJ: Bacteriostatic and bactericidal activities of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium. Tubercle 1987, 68:267-276.
5. Iseman MD: Drug therapy: treatment of multidrug resistant tuberculosis. N Engl J Mcd 1993, 329:784-791.
6. Sullivan EA, Kreiswirth BN, Palumbo L, et al.: Emergence of fluoroquinolone resistant tuberculosis in New York City. Lancet 1995, 345:1148-1150.
7. Salomon N, Perlman DC, Friedmann P, Buchstein S, Kreiswirth BN, Mildvan D: Predictors and outcome of multidrug-resistant tuberculosis. Clin Infec Dis 1995, 21:1245-1252.
8. Ji B, Lounic N, Truffot-Pernot C, Grosset J: In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis Antimicrob Agents Chemother 1995, 39:1341-1344.
9. Saito H, Sato K, Tomioka H, Dekio S: In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355) Tubercle Lung Dis 1995, 76:377-380.
10. Mor N, Vanderkolk J, Heifets L: Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages. Antimicrob Agents Chemother 1994, 38:1161-1164.
11. Klemens SP, Sharpe CA, Rogge MC, Cynamon MH: Activity of levofloxacin in a murine model of tuberculosis Antimicrob Agents Chemother 1994, 38:1476-1479.
12. Rastogi N, Goh KS, Bryskier A, Devallois A: In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis. Antimicrobial Agents Chemother. 1996, 40:1610-1616.
13. El Sadr WE, Perlman DC, Matts JP, et al.: Outcomes of an intermittent induction regimen for HIV-related pulmonary tuberculosis. XIth International Conference on AIDS. Vancouver, July, 1996 [abstract Tu.B.2358].
14. van Embden JDA, Cave MD, Crawford IT, et al.: Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993, 31:406-409.
15. Tsukamura M, Nakumura E, Yoshii S, Amano H: Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis. Am Rev Respir Dis 1985, 131:352-356.
16. Kapur V, Li EL, Hamrick MR, Plikaytis BB, et al.: Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA Arch Pathol Lab Med 1995, 119:131-137.
17. Takif HE, Salazar L, Guerrero C, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations Antimicrob Agents Chemother 1994, 38:773-780.
18. Cambau E, Sougakoff W, Besson M: Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin. J Infect Dis 1994, 170:479-483.
19. Kocagoz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaldo H, Chambers HE: Gyrase mutations in laboratory selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37RA. Antimicro Agents Chemother 1996, 40:1768-1774.
20. Musser JM: Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995, 8:496-514.
21. Small PM, Hopewell PC, Singh SP, et al.: The epidemiology of tuberculosis in San Francisco: a population based study using conventional and molecular methods. N Engl J Med 1994, 330:1703-1709.
22. van Soolingen D, de Haas PE, Hermans PW, Groenen PM, van Embden JD: Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol 1993, 31:1987-1995.
23. Bifani PJ, Plikaytis BP, Kapur V, et al.: Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996, 275:452-457.
24. Frieden TR, Mangi RJ: Inappropriate use of oral ciprofloxacin. JAMA 1990, 264:1438-1440.
25. Centers for Disease Control: Management of persons exposed to multidrug-resistant tuberculosis MMWR 1992, 41 (RR-11):59-71.
26. O'Brien RJ: The treatment of tuberculosis. In: Tuberculosis: A Comorehensive International Approach. Edited by Reichman LB, Hershfield ES. New York: Marcel Dekker; 1993:207-240.
27. Casper C, Singh SP, Rane S, et al.: The transcontinental transmission of tuberculosis: a molecular assessment. Am J Public Health 1996, 86:551-553.